Barbara Corkey, a Ph.D. professor emeritus of medicine and biochemistry at BUSM explained that previous studies have focused on the triggers, genes, and proteins that differentiate individuals with T1D from those without diabetes with a focus on the b-cell which create antibodies, as a target of immune destruction and blood glucose as the main abnormality.